The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
 
Antonio Marcilio Padula Omuro
Consulting or Advisory Role - Bristol-Myers Squibb; Juno Therapeutics; Stemline Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Juno Therapeutics
 
Kathryn Beal
No Relationships to Disclose
 
Katharine Anne McNeill
No Relationships to Disclose
 
Alissa A. Thomas
No Relationships to Disclose
 
Xuling Lin
No Relationships to Disclose
 
Thomas Joseph Kaley
No Relationships to Disclose
 
Lisa Marie DeAngelis
No Relationships to Disclose
 
Ingo K. Mellinghoff
No Relationships to Disclose
 
Eli L. Diamond
No Relationships to Disclose
 
Timothy An-thy Chan
No Relationships to Disclose
 
Robert J. Young
No Relationships to Disclose
 
Yoshiya Yamada
No Relationships to Disclose
 
Greg Gorman
No Relationships to Disclose
 
Michael Lamson
Employment - Nuventra
Consulting or Advisory Role - Tactical Therapeutics
 
Linda M. Bavisotto
No Relationships to Disclose
 
Rashida A. Karmali
Employment - Tactical Therapeutics
Leadership - Tactical Therapeutics
Stock and Other Ownership Interests - Tactical Therapeutics
Patents, Royalties, Other Intellectual Property - Tactical Therapeutics